• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CARDIOVASCULAR SYSTEMS, INC. STEALTH ORBITAL ATHERECTOMY SYSTEM; PERIPHERAL ATHERECTOMY DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CARDIOVASCULAR SYSTEMS, INC. STEALTH ORBITAL ATHERECTOMY SYSTEM; PERIPHERAL ATHERECTOMY DEVICE Back to Search Results
Model Number DBE-200
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Embolism (1829)
Event Date 07/16/2020
Event Type  Injury  
Manufacturer Narrative
The results of the investigation are inconclusive since the reported device was not returned for analysis.Based on the information received, the cause of the reported event could not be conclusively determined.The device history record for this oad lot number has been reviewed.No issues or discrepancies were noted during this review that would have contributed to the reported event.The device met material, assembly, and quality control requirements.(b)(4).
 
Event Description
During a peripheral procedure, a csi orbital atherectomy device was used to treat a lesion from the superficial femoral artery (sfa) through the anterior tibial (at) artery.The lesion had 60-80% stenosis, was heavily calcified, and the vessels had mild tortuosity.The at was treated with balloon angioplasty, and orbital atherectomy was then performed from the sfa to the popliteal artery with 6 treatments on low speed, 3 treatments on medium speed, and 6 treatments on high speed.Additional balloon angioplasty was performed from the popliteal artery through the at.Haziness was identified on imaging in the mid-at.It was noted that flow after orbital atherectomy had been normal.Small, hard, white matter was aspirated, and the haziness was no longer visible under fluoroscopy.The opinion of the physician was that the white matter was a result of orbital atherectomy.Additional balloon angioplasty was performed in the sfa to complete the procedure with satisfactory results.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STEALTH ORBITAL ATHERECTOMY SYSTEM
Type of Device
PERIPHERAL ATHERECTOMY DEVICE
Manufacturer (Section D)
CARDIOVASCULAR SYSTEMS, INC.
1225 old highway 8 nw
saint paul, mn
Manufacturer (Section G)
CARDIOVASCULAR SYSTEMS, INC.
1225 old highway 8 nw
saint paul, mn
Manufacturer Contact
sarah hicks
1225 old highway 8 nw
saint paul, mn 
MDR Report Key10391958
MDR Text Key202410685
Report Number3004742232-2020-00238
Device Sequence Number1
Product Code MCW
UDI-Device Identifier10850000491080
UDI-Public(01)10850000491080(17)211231(10)250579
Combination Product (y/n)N
Reporter Country CodeMY
PMA/PMN Number
K190634
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Reporter Occupation Physician
Type of Report Initial
Report Date 08/11/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/11/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/31/2021
Device Model NumberDBE-200
Device Lot Number250579
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/16/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/05/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age59 YR
-
-